Roth Capital Downgrades CorMedix (CRMD) to Neutral
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Price: $8.83 -0.45%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Join SI Premium – FREE
Roth Capital downgraded CorMedix (NYSE: CRMD) from Buy to Neutral with a price target of $7.50 (from $2.50).
For an analyst ratings summary and ratings history on CorMedix click here. For more ratings news on CorMedix click here.
Shares of CorMedix closed at $7.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- King Slide Works Co Ltd (2059:TT) PT Raised to NT$12,000 at Goldman Sachs
- JPMorgan Downgrades Stellantis NV (STLA:IM) (STLA) to Neutral
- Lantronix, Inc. (LTRX) PT Raised to $11 at Canaccord
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
